Kalmar Investments’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-117,035
Closed -$14M 91
2016
Q4
$14M Sell
117,035
-18,105
-13% -$2M 0.72% 73
2016
Q3
$15.2M Sell
135,140
-6,305
-4% -$726K 0.69% 72
2016
Q2
$17.5M Sell
141,445
-42,295
-23% -$5.11M 0.77% 54
2016
Q1
$20.7M Sell
183,740
-172,980
-48% -$18M 0.85% 48
2015
Q4
$38.8M Sell
356,720
-14,070
-4% -$1.61M 0.95% 46
2015
Q3
$37M Sell
370,790
-4,335
-1% -$471K 0.87% 51
2015
Q2
$42.8M Sell
375,125
-1,320
-0.4% -$160K 0.81% 51
2015
Q1
$39.3M Buy
376,445
+180,570
+92% +$19.2M 0.73% 56
2014
Q4
$23.6M Sell
195,875
-131,370
-40% -$17.3M 0.44% 80
2014
Q3
$47.9M Hold
327,245
0.91% 43
2014
Q2
$54.7M Buy
327,245
+4,790
+1% +$852K 0.94% 38
2014
Q1
$64M Sell
322,455
-135
-0% -$25.5K 1.08% 26
2013
Q4
$61.6M Buy
322,590
+3,620
+1% +$674K 1.03% 31
2013
Q3
$54M Sell
318,970
-112,309
-26% -$17.4M 0.95% 34
2013
Q2
$65.4M Buy
+431,279
New +$61.1M 1.29% 17

Other funds holding CLB

Kalmar Investments's CLB Position: Q1 2017 in Review

Kalmar Investments sold out of Core Laboratories (CLB) in Q1 2017, closing a stake of 117,035 shares — an estimated $14M sold.

Kalmar Investments first reported a position in CLB in Q2 2013 and held it in 15 quarters. The position peaked at $65.4M in Q2 2013. 360 funds tracked by Wall St. Rank hold CLB as of Q1 2017.

  • Kalmar Investments reported no remaining Core Laboratories position as of Q1 2017 after selling out during the quarter.
  • Kalmar Investments sold 117,035 Core Laboratories shares in Q1 2017, an estimated $14M.
  • Kalmar Investments first reported a position in Core Laboratories in Q2 2013 and held it in 15 quarters.
  • Kalmar Investments's Core Laboratories position peaked at $65.4M in Q2 2013.
  • 360 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2017.

Based on Kalmar Investments's 13F filing for Q1 2017, filed 26 Apr 2017.